Background Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious
adverse effect of certain drugs, of which bisphosphonates are the most widely known. This …

Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD), a
category of immunodeficiencyassociated LPD according to the World Health Organization …

With the advancements in conventional treatment modalities such as radiation,
chemotherapy, and surgery, as well as the emergence of immunotherapy, the overall cure …

Il trattamento di ONJ è, dalla sua comparsa in letteratura, argomento molto dibattuto, prima,
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …

Aims Medication‐related osteonecrosis of the jaw (MRONJ) is an uncommon but potentially
debilitating condition, characterised by nonhealing jawbone, with or without mucosal …

The aim was to search systematically, evaluate, and then summarize scientific literature
about possible methotrexate-associated osteonecrosis of the jaw (ONJ), its signs and …

Osteonecrosis of the jaw (ONJ) is an increasingly common condition primarily due to the rise
of medication related osteonecrosis of the jaw (MRONJ) and osteoradionecrosis (ORN) …

Chemotherapy is one of the most popular therapeutic strategies to treat cancer. However,
cancer chemotherapeutics have often been associated with impairment of the immune …

Objective Osteonecrosis of the jaw (ONJ) is commonly associated with antiresorptive
therapy. There have been numerous reports of ONJ unrelated to antiresorptive therapy (ONJ …

Oral manifestations of side effects of medications, such as methotrexate (MTX) for
management of rheumatoid arthritis (RA) and mycophenolate mofetil (MMF) for solid organ …